Trials / Unknown
UnknownNCT05901454
Yellow Fever Human Infection Model With YF-17D
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Leiden University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
No antiviral treatment exists for yellow fever, only supportive care, and therefore we rely on prevention through vaccination. Although this vaccine is very effective, stockpiles are insufficient in outbreak situations and some people have a contraindication to be vaccinated. For those who are unprotected and at risk of yellow fever infection, treatment could be life saving.
Detailed description
No antiviral treatment exists for yellow fever, only supportive care, and therefore we rely on prevention through vaccination. Although this vaccine is very effective, stockpiles are insufficient in outbreak situations and some people have a contraindication to be vaccinated. For those who are unprotected and at risk of yellow fever infection, treatment could be life saving.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Yellow Fever Vaccine | vaccination according to manufacturers manual (0.5mL subcutaneously in the arm) |
Timeline
- Start date
- 2023-02-17
- Primary completion
- 2023-07-01
- Completion
- 2024-03-01
- First posted
- 2023-06-13
- Last updated
- 2023-06-13
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05901454. Inclusion in this directory is not an endorsement.